Literature DB >> 36438

7alpha-Dehydroxylation of cholic acid and chenodeoxycholic acid by Clostridium leptum.

E J Stellwag, P B Hylemon.   

Abstract

The rate of 7alpha-dehydroxylation of primary bile acids was quantitatively measured radiochromatographically in anaerobically washed whole cell suspensions of Clostridium leptum. The pH optimum for the 7alpha-dehydroxylation of both cholic and chenodeoxycholic acid was 6.5-7.0. Substrate saturation curves were observed for the 7alpha-dehydroxylation of cholic and chenodeoxycholic acid. However, cholic acid whole cell K0.5 (0.37 micron) and V (0.20 mumol hr-1mg protein-1) values differed significantly from chenodeoxycholic acid whole cell K0.5 (0.18 micron) and V (0.50 mumol-1 hr-1 mg protein-1). 7alpha-Dehydroxylation activity was not detected using glycine and taurine-conjugated primary bile acids, ursodeoxycholic acid, cholic acid methyl ester, or hyocholic acid as substrates. Substrate competition experiments showed that cholic acid 7 alpha-dehydroxylation was reduced by increasing concentrations of chendeoxycholic acid; however, chenodeoxycholic acid 7alpha-dehydroxylation activity was unaffected by increasing concentrations of cholic acid. A 10-fold increase in cholic and 7alpha-dehydroxylation activity occurred during the transition from logarithmic to stationary phase growth whether cells were cultured in the presence or absence of sodium cholate. In the same culture, a similar increase in chenodeoxycholic acid 7alpha-dehydroxylation was detected only in cells cultured in the presence of sodium cholate. These results indicate the possible existence of two independent systems for 7alpha-dehydroxylation in C. Leptum.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 36438

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  39 in total

Review 1.  Gastrointestinal dysbiosis and the use of fecal microbial transplantation in Clostridium difficile infection.

Authors:  L Patrick Schenck; Paul L Beck; Justin A MacDonald
Journal:  World J Gastrointest Pathophysiol       Date:  2015-11-15

2.  Assessment of fecal bacteria with bile acid 7 alpha-dehydroxylating activity for the presence of bai-like genes.

Authors:  K C Doerner; F Takamine; C P LaVoie; D H Mallonee; P B Hylemon
Journal:  Appl Environ Microbiol       Date:  1997-03       Impact factor: 4.792

3.  Increasing butyrate concentration in the distal colon by accelerating intestinal transit.

Authors:  S J Lewis; K W Heaton
Journal:  Gut       Date:  1997-08       Impact factor: 23.059

Review 4.  Deoxycholic acid and the pathogenesis of gall stones.

Authors:  S N Marcus; K W Heaton
Journal:  Gut       Date:  1988-04       Impact factor: 23.059

5.  Composition of cecal bile acids in ex-germfree mice inoculated with human intestinal bacteria.

Authors:  S Narushima; K Ito; K Kuruma; K Uchida
Journal:  Lipids       Date:  2000-06       Impact factor: 1.880

6.  Delta 22-beta-muricholic acid in monoassociated rats and conventional rats.

Authors:  T Kayahara; T Tamura; Y Amuro; K Higashino; H Igimi; K Uchida
Journal:  Lipids       Date:  1994-04       Impact factor: 1.880

7.  Cooperative formation of omega-muricholic acid by intestinal microorganisms.

Authors:  H Eyssen; G De Pauw; J Stragier; A Verhulst
Journal:  Appl Environ Microbiol       Date:  1983-01       Impact factor: 4.792

8.  7 alpha-Dehydroxylation of bile acids by resting cells of a Eubacterium lentum-like intestinal anaerobe, strain c-25.

Authors:  N Masuda; H Oda; S Hirano; M Masuda; H Tanaka
Journal:  Appl Environ Microbiol       Date:  1984-04       Impact factor: 4.792

9.  High concentration and retained amidation of fecal bile acids in patients with active ulcerative colitis.

Authors:  N Tanida; Y Hikasa; M Dodo; K Sawada; A Kawaura; T Shimoyama
Journal:  Gastroenterol Jpn       Date:  1986-06

10.  Molecular cloning of bile acid 7-dehydroxylase from Eubacterium sp. strain VPI 12708.

Authors:  J P Coleman; W B White; P B Hylemon
Journal:  J Bacteriol       Date:  1987-04       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.